We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Characteristics of Patients With Thymoma in Chulalongkorn Hospital

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01123590
Recruitment Status : Completed
First Posted : May 14, 2010
Last Update Posted : November 23, 2010
Sponsor:
Information provided by:

Study Description
Brief Summary:
The purpose of this study is to study characteristics of patients with thymoma in Chulalongkorn hospital between 2003-2007.

Condition or disease
Thymoma Staging Clinical Presentations Associated Disorders Laboratory Findings

Detailed Description:
To study characteristics of patients with thymoma undergone thymectomy in Chulalongkorn hospital between 2003-2007 in terms of clinical manifestations, associated diseases, and laboratory findings.

Study Design

Study Type : Observational
Actual Enrollment : 50 participants
Observational Model: Case Control
Time Perspective: Retrospective
Official Title: Characteristics of Patients With Thymoma Undergone Thymectomy in Chulalongkorn Hospital Between 2003-2007
Study Start Date : November 2009
Primary Completion Date : April 2010
Study Completion Date : October 2010

Resource links provided by the National Library of Medicine

U.S. FDA Resources

Groups and Cohorts

Group/Cohort
Thymoma
Patients with thymoma
Control
Normal controls


Outcome Measures

Primary Outcome Measures :
  1. Thymoma staging and clinical manifestations [ Time Frame: 5 years ]

Secondary Outcome Measures :
  1. Associated diseases and laboratory findings Immunological data [ Time Frame: 4 months ]

Biospecimen Retention:   Samples Without DNA
PBMC

Eligibility Criteria

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   Child, Adult, Senior
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Sampling Method:   Non-Probability Sample
Study Population
Patients with thymoma undergone thymectomy in Chulalongkorn hospital between 2003-2007
Criteria

Inclusion Criteria:

  • Patients with histocytological proved thymoma undergone thymectomy in Chulalongkorn hospital between 2003-2007

Exclusion Criteria:

Contacts and Locations

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01123590


Locations
Thailand
Faculty of Medicine, Chulalongkorn University
Bangkok, Thailand, 10330
Sponsors and Collaborators
Chulalongkorn University
Investigators
Principal Investigator: Jettanong Klaewsongkram, MD Chulalongkorn University
More Information

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Responsible Party: Jettanong Klaewsongkram, Chulalongkorn University
ClinicalTrials.gov Identifier: NCT01123590     History of Changes
Other Study ID Numbers: Chula-ARC 003/09
First Posted: May 14, 2010    Key Record Dates
Last Update Posted: November 23, 2010
Last Verified: November 2010

Keywords provided by Chulalongkorn University:
Thymoma
Autoimmune diseases
Immunodeficiency

Additional relevant MeSH terms:
Thymoma
Thymus Neoplasms
Neoplasms, Complex and Mixed
Neoplasms by Histologic Type
Neoplasms
Thoracic Neoplasms
Neoplasms by Site
Lymphatic Diseases